STOCK TITAN

MarineMax stake of 4.3% reported by American Century

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

MarineMax, Inc. (HZO) is the subject of an amended Schedule 13G filing (Amendment No. 10) reporting that American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research collectively report beneficial ownership of 943,128 shares of MarineMax common stock, representing 4.3% of the class.

The reporting entities disclose 927,757 shares with sole voting power and 943,128 shares with sole dispositive power, with no shared voting or dispositive power. The filing also notes that various advisory clients of American Century Investment Management have the right to receive dividends and sale proceeds, and that no single client holds more than 5% of the class.

Positive

  • None.

Negative

  • None.
Beneficially owned shares 943,128 shares MarineMax, Inc. common stock reported as beneficially owned by the group
Percent of class 4.3% Portion of MarineMax, Inc. common stock outstanding represented by 943,128 shares
Sole voting power 927,757 shares Shares of MarineMax, Inc. over which the reporting entities have sole voting power
Shared voting power 0 shares Shares of MarineMax, Inc. over which the reporting entities have shared voting power
Sole dispositive power 943,128 shares Shares of MarineMax, Inc. over which the reporting entities have sole dispositive power
Shared dispositive power 0 shares Shares of MarineMax, Inc. over which the reporting entities have shared dispositive power
Schedule 13G regulatory
"beneficial ownership of the securities that are the subject of this schedule"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficial owner financial
"that is a beneficial owner of securities that are subject of this schedule"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
Sole Voting Power financial
"5 | Sole Voting Power 927,757.00 6 | Shared Voting Power"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Sole Dispositive Power financial
"7 | Sole Dispositive Power 943,128.00 8 | Shared Dispositive Power"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Investment adviser financial
"an investment adviser registered under Section 203 of the Investment Advisers Act of 1940"
An investment adviser is a person or firm that professionally manages money and gives recommendations about buying, selling, or holding investments. Like a financial coach or guide, they have a legal duty to act in a client's best financial interest, so their advice, fees and potential conflicts can directly affect returns and risk — making their role important for investors who want informed, accountable help with portfolios.

FAQ

What ownership stake in MarineMax, Inc. (HZO) is reported in this Schedule 13G/A?

The filing reports beneficial ownership of 943,128 shares of MarineMax, Inc. common stock, representing 4.3% of the outstanding class as disclosed by the reporting entities.

Who are the reporting persons in this MarineMax (HZO) Schedule 13G/A?

The reporting persons are American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research, which together report beneficial ownership of the disclosed MarineMax shares.

How many MarineMax (HZO) shares have sole voting power in this filing?

The filing states that the reporting entities have sole voting power over 927,757 shares of MarineMax, Inc. common stock and no shared voting power.

What dispositive power over MarineMax (HZO) shares is disclosed?

The reporting entities report sole dispositive power over 943,128 shares of MarineMax, Inc. common stock and no shared dispositive power, meaning they alone can direct the disposition of these shares.

Do any American Century clients own more than 5% of MarineMax (HZO)?

The filing states that various clients of American Century Investment Management may receive dividends or sale proceeds, but that no single client owns more than 5% of the MarineMax common stock class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



American Century Investment Management, Inc.
Signature:American Century Investment Management, Inc.
Name/Title:/s/ John Pak / Senior Vice President
Date:09/04/2026
American Century Companies, Inc.
Signature:American Century Companies, Inc.
Name/Title:/s/ John Pak / Senior Vice President
Date:09/04/2026
Stowers Institute for Medical Research
Signature:Stowers Institute for Medical Research
Name/Title:/s/ Joselyn Verschelden / Authorized Signer
Date:09/04/2026
Exhibit Information

EXHIBIT Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule. Dated this 4th day of September, 2026. AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. ("ACIM") AMERICAN CENTURY COMPANIES, INC. ("ACC") By: __/s/ John Pak_________________ John Pak Senior Vice President, ACIM and ACC STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC By: __/s/ Joselyn Verschelden_______ Joselyn Verschelden Authorized Signer

Keep reading